PULMATRIX

pulmatrix-logo

Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSEโ„ข technology. The Company's proprietary product pipeline is initially focused on advancing treatments for serious lung diseases, including Pulmazole, an inhaled anti-fungal for patients with ABPA, and PUR1800, a narrow spectrum kinase inhibitor in lung cancer. Pulmatrix's product candidates are based on iSPERSEโ„ข, its proprietary engineered dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by achieving optimal local drug concentrations and reducing systemic side effects to improve patient outcomes.

#SimilarOrganizations #People #Financial #Website #More

PULMATRIX

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2003-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.pulmatrix.com

Total Employee:
11+

Status:
Active

Contact:
(781)357-2399

Email Addresses:
[email protected]

Total Funding:
148.42 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Font Awesome Apache Microsoft Exchange Online Office 365 Mail IPv6


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

mapp-biopharmaceutical-logo

Mapp Biopharmaceutical

Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.


Current Advisors List

steven-gillis_image

Steven Gillis Member of the Board of Directors @ Pulmatrix
Board_member

scott-m-rocklage_image

Scott M. Rocklage Board of Directors @ Pulmatrix
Board_member

david-maki_image

David Maki Board of Directors @ Pulmatrix
Board_member

terrance-mcguire_image

Terrance McGuire Member of the Board of Directors @ Pulmatrix
Board_member

richard-j-ulevitch_image

Richard J. Ulevitch Scientific Advisory Board @ Pulmatrix
Advisor

kevin-bitterman_image

Kevin Bitterman Board Observer @ Pulmatrix
Board_observer

lauren-silverman_image

Lauren Silverman Member of the Board of Directors @ Pulmatrix
Board_member

not_available_image

David N. Edwards Board of Directors @ Pulmatrix
Board_member

Current Employees Featured

not_available_image

Mark J. Gabrielson
Mark J. Gabrielson Founder & Board of Directors @ Pulmatrix
Founder & Board of Directors

alexander-klibanov_image

Alexander Klibanov
Alexander Klibanov Co-Founder @ Pulmatrix
Co-Founder
2003-01-01

jean-sung_image

Jean Sung
Jean Sung Vice President of Pharmaceutical Development @ Pulmatrix
Vice President of Pharmaceutical Development
2008-01-01

robert-clarke_image

Robert Clarke
Robert Clarke CEO & Board of Directors @ Pulmatrix
CEO & Board of Directors
2012-01-01

Founder


alexander-klibanov_image

Alexander Klibanov

not_available_image

Mark J. Gabrielson

Stock Details


Company's stock symbol is NASDAQ:PULM

Investors List

national-heart-lung-and-blood-institute_image

National Heart, Lung and Blood Institute

National Heart, Lung and Blood Institute investment in Grant - Pulmatrix

polaris-partners_image

Polaris Partners

Polaris Partners investment in Post-IPO Equity - Pulmatrix

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Post-IPO Equity - Pulmatrix

altitude-life-science-ventures_image

Altitude Life Science Ventures

Altitude Life Science Ventures investment in Post-IPO Equity - Pulmatrix

5am-ventures_image

5AM Ventures

5AM Ventures investment in Post-IPO Equity - Pulmatrix

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series B - Pulmatrix

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series B - Pulmatrix

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series B - Pulmatrix

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series B - Pulmatrix

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series B - Pulmatrix

Official Site Inspections

http://www.pulmatrix.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.63 K

  • Host name: 209.114.180.107.host.secureserver.net
  • IP address: 107.180.114.209
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Pulmatrix" on Search Engine